Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan

SIMPLE SUMMARY: The aim of this study was to evaluate treatment patterns and real-world clinical outcomes since immunotherapy was introduced in Japan as the initial (first-line) therapy for treating patients with lung cancer, the leading cause of cancer-related deaths in Japan. For 1182 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Nokihara, Hiroshi, Kijima, Takashi, Yokoyama, Toshihide, Kagamu, Hiroshi, Suzuki, Takuji, Mori, Masahide, Santorelli, Melissa L., Taniguchi, Kazuko, Kamitani, Tetsu, Irisawa, Masato, Kanda, Kingo, Abe, Machiko, Burke, Thomas, Goto, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220782/
https://www.ncbi.nlm.nih.gov/pubmed/35740512
http://dx.doi.org/10.3390/cancers14122846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220782/
https://www.ncbi.nlm.nih.gov/pubmed/35740512
http://dx.doi.org/10.3390/cancers14122846

Ejemplares similares